Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aisner

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposideC P Belani, M J Egorin, J S Abrams, et al.
Cancer|June 8, 2001
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trialP J Loehrer, M Jiroutek, S Aisner, et al.
Blood|August 1, 1983
Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infectionJ P Dutcher, C A Schiffer, G S Johnston, et al.
The American Journal of the Medical Sciences|June 1, 1986
Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemiaN S Tchekmedyian, K Newman, M R Moody, et al.
American Journal of Clinical Oncology|April 1, 1983
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lungJ Z Fuks, J Aisner, D A Van Echo, et al.
AJR. American Journal of Roentgenology|May 1, 1984
Computed tomography of the chest in small cell lung cancer: potential new prognostic signsN O Whitley, J Z Fuks, E S McCrea, et al.
Cancer|February 1, 1984
Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumorsJ P Dutcher, C A Schiffer, J Aisner, et al.
Cancer Treatment Reports|January 1, 1976
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemiaP H Wiernik, S C Schimpff, C A Schiffer, et al.
Cancer Investigation|January 1, 1990
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443D R Budman, A H Korzun, J Aisner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281J Aisner, C Cirrincione, M Perloff, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposideC P Belani, M J Egorin, J S Abrams, et al.
Cancer|June 8, 2001
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trialP J Loehrer, M Jiroutek, S Aisner, et al.
Blood|August 1, 1983
Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infectionJ P Dutcher, C A Schiffer, G S Johnston, et al.
The American Journal of the Medical Sciences|June 1, 1986
Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemiaN S Tchekmedyian, K Newman, M R Moody, et al.
American Journal of Clinical Oncology|April 1, 1983
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lungJ Z Fuks, J Aisner, D A Van Echo, et al.
AJR. American Journal of Roentgenology|May 1, 1984
Computed tomography of the chest in small cell lung cancer: potential new prognostic signsN O Whitley, J Z Fuks, E S McCrea, et al.
Cancer|February 1, 1984
Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumorsJ P Dutcher, C A Schiffer, J Aisner, et al.
Cancer Treatment Reports|January 1, 1976
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemiaP H Wiernik, S C Schimpff, C A Schiffer, et al.
Cancer Investigation|January 1, 1990
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443D R Budman, A H Korzun, J Aisner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281J Aisner, C Cirrincione, M Perloff, et al.
Pageof 24